Claiborne Daniel T, Prince Jessica L, Scully Eileen, Macharia Gladys, Micci Luca, Lawson Benton, Kopycinski Jakub, Deymier Martin J, Vanderford Thomas H, Nganou-Makamdop Krystelle, Ende Zachary, Brooks Kelsie, Tang Jianming, Yu Tianwei, Lakhi Shabir, Kilembe William, Silvestri Guido, Douek Daniel, Goepfert Paul A, Price Matthew A, Allen Susan A, Paiardini Mirko, Altfeld Marcus, Gilmour Jill, Hunter Eric
Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139;
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):E1480-9. doi: 10.1073/pnas.1421607112. Epub 2015 Feb 17.
HIV-1 infection is characterized by varying degrees of chronic immune activation and disruption of T-cell homeostasis, which impact the rate of disease progression. A deeper understanding of the factors that influence HIV-1-induced immunopathology and subsequent CD4(+) T-cell decline is critical to strategies aimed at controlling or eliminating the virus. In an analysis of 127 acutely infected Zambians, we demonstrate a dramatic and early impact of viral replicative capacity (vRC) on HIV-1 immunopathogenesis that is independent of viral load (VL). Individuals infected with high-RC viruses exhibit a distinct inflammatory cytokine profile as well as significantly elevated T-cell activation, proliferation, and CD8(+) T-cell exhaustion, during the earliest months of infection. Moreover, the vRC of the transmitted virus is positively correlated with the magnitude of viral burden in naive and central memory CD4(+) T-cell populations, raising the possibility that transmitted viral phenotypes may influence the size of the initial latent viral reservoir. Taken together, these findings support an unprecedented role for the replicative fitness of the founder virus, independent of host protective genes and VL, in influencing multiple facets of HIV-1-related immunopathology, and that a greater focus on this parameter could provide novel approaches to clinical interventions.
HIV-1感染的特征是不同程度的慢性免疫激活和T细胞稳态破坏,这会影响疾病进展速度。深入了解影响HIV-1诱导的免疫病理学及随后CD4(+) T细胞减少的因素,对于旨在控制或消除该病毒的策略至关重要。在对127名急性感染的赞比亚人进行的分析中,我们证明了病毒复制能力(vRC)对HIV-1免疫发病机制具有显著且早期的影响,且该影响独立于病毒载量(VL)。在感染的最初几个月里,感染高复制能力病毒的个体表现出独特的炎性细胞因子谱,以及显著升高的T细胞激活、增殖和CD8(+) T细胞耗竭。此外,传播病毒的vRC与初始和中枢记忆CD4(+) T细胞群体中的病毒载量大小呈正相关,这增加了传播病毒表型可能影响初始潜伏病毒库大小的可能性。综上所述,这些发现支持了奠基病毒的复制适应性在影响HIV-1相关免疫病理学多个方面中具有前所未有的作用,该作用独立于宿主保护基因和VL,并且更加关注这一参数可能为临床干预提供新方法。